Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?
Anemia is a common complication of chronic kidney disease (CKD). The most common cause of anemia in CKD is erythropoietin deficiency; and the most important cause of mortality in CKD patients is atherosclerotic vascular complications which are associated with endothelial damage. One of the methods...
| Prif Awduron: | , , , , , , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
National Kidney Foundation of Ukraine
2020-10-01
|
| Cyfres: | Український Журнал Нефрології та Діалізу |
| Pynciau: | |
| Mynediad Ar-lein: | https://ukrjnd.com.ua/index.php/journal/article/view/446 |